Addendum: REST and stress resistance in ageing and Alzheimer's disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Immunosenescence: molecular mechanisms and diseases.Signal transduction and targeted therapy · 2023
   Review
2. Epigenetics of Aging and Aging-Associated Diseases.International journal of molecular sciences · 2021
   Review
3. LSD1 is an environmental stress-sensitive negative modulator of the glutamatergic synapse.Neurobiology of stress · 2020
   Article
4. Phenotypic modulation of pentylenetetrazole-induced convulsive behaviors inmicroPublication biology · 2020
   Article
5. Evolution of DNAase I Hypersensitive Sites in MHC Regulatory Regions of Primates.Genetics · 2018
   Article
6. Religious Orders Study and Rush Memory and Aging Project.Journal of Alzheimer's disease : JAD · 2018
   Review
7. AlternativeeNeuro
   Article

Corrections and comments

• Commented on by
  Alternative
• Erratum for
  REST and stress resistance in ageing and Alzheimer's disease.2014

Authors and funding

13 authors.

Funding

Abstract

PubMed holds no abstract for this paper.